The age-related decrease in skeletal muscle mass together with the loss of muscle power
and function is defined sarcopenia. Mounting evidence suggests that the prevalence of …

Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and
function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal …

Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has
become a common hallmark of ageing and many chronic diseases. Diabetes mellitus …

Sarcopenia, defined as the loss of skeletal muscle mass and strength and/or a decrease in
physical performance, is classically related to aging. However, chronic disease, including …

Sarcopenia, the age-related loss of muscle strength and mass or quality, is a common
condition with major adverse consequences. Although the pathophysiology is incompletely …

Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

The incidence and prevalence of metabolic and musculoskeletal diseases are increasing.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation …

Sarcopenia is an age-related clinical complaint characterized by the progressive
deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is …

Diabetes prevalence is increasing rapidly in older people, and sarcopenia is prevalent as a
novel complication, particularly in patients with type 2 diabetes mellitus (T2DM). Therefore …

Objectives Type 2 diabetes is a risk factor for sarcopenia. Evidence on the prevention of
sarcopenia using blood glucose–lowering therapy is limited. We aimed to examine the …